Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

KRX/004720 stock hub

KRX/004720 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KRX/004720is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
87.9B
Korea Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
KRX/004720
In the news

Latest news · KRX/004720

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.8P50 17.1P75 31.9
Trailing P/E746.2
P25 12P50 23.1P75 39.5
ROE0.1
P25 -17.1P50 0.7P75 8.5
ROIC3.8
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KRX/004720 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
205
Groups with data
11
Currency
KRW
Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
226
Enterprise value
KRW 93.2B
Exchange
Korea Stock Exchange
Financial currency
KRW
First seen
2026-05-10
Industry
Drug Manufacturers - General
Isin
KR7004720009
Last refreshed
2026-05-10
Market cap
KRW 87.9B
Price
KRW 4,010
Price currency
KRW
Rev Per Employee
759,549,580.04x
Sector
Healthcare
Sic
2834
Symbol
krx/004720
Website
https://www.wooridulpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
0.13%
EV Earnings
791.64x
EV/EBIT
40.47x
EV/EBITDA
13.45x
EV/FCF
-48.06x
EV/Sales
0.54x
FCF yield
-2.21%
P/B ratio
0.35x
P/E ratio
746.24x
P/S ratio
0.51x
PE Ratio10 Y
60.58x
PE Ratio3 Y
74.67x
PE Ratio5 Y
53.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
5.63%
EBITDA Margin
8.32%
Gross margin
63.12%
Gross Profit
KRW 108.4B
Gross Profit Growth
6.06%
Gross Profit Growth Q
1.84%
Gross Profit Growth3 Y
16.25%
Gross Profit Growth5 Y
16.63%
Net Income
KRW 117.7M
Net Income Growth
-98.21%
Net Income Growth Years
0%
Net Income Growth3 Y
-87.99%
Pretax Margin
-1.3%
Profit Margin
0.07%
Profit Per Employee
KRW 521,017
ROA
1.76
Roa5y
0.52
ROCE
3.25
ROE
0.05
Roe5y
17.94
ROIC
3.83
Roic5y
0.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr10y
-6.95%
Cagr15y
-2.98%
Cagr1y
0.25%
Cagr20y
-8.92%
Cagr3y
-14.78%
Cagr5y
-20.47%
EPS Growth
-98.08
EPS Growth Years
0
EPS Growth3 Y
-87.95
Revenue Growth
-0.02x
Revenue Growth Q
0.87x
Revenue Growth Years
14x
Revenue Growth3 Y
10.62x
Revenue Growth5 Y
12.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
KRW 0.5
Assets
KRW 340.2B
Cash
KRW 14.1B
Current Assets
KRW 90.1B
Current Liabilities
KRW 43.4B
Debt
KRW 19.4B
Debt EBITDA
KRW 1.36
Debt Equity
KRW 0.08
Debt FCF
KRW -10.01
Equity
KRW 248.7B
Interest Coverage
2.32
Liabilities
KRW 91.5B
Long Term Assets
KRW 250B
Long Term Liabilities
KRW 48.2B
Net Cash
KRW -5.3B
Net Cash By Market Cap
KRW -6.08
Net Debt EBITDA
KRW 0.37
Net Debt Equity
KRW 0.02
Tangible Book Value
KRW 248.2B
Tangible Book Value Per Share
KRW 13,667
WACC
7.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.08
Inventory Turnover
2.28
Net Working Capital
KRW 51.8B
Quick ratio
1.26
Working Capital
KRW 46.8B
Working Capital Turnover
KRW 4.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-51.33%
1Y total return
0.25%
200-day SMA
4,148.1
3Y total return
-38.12%
50-day SMA
3,818.5
50-day SMA vs 200-day SMA
50under200
5Y total return
-68.17%
All Time High
39,400
All Time High Change
-89.82%
All Time High Date
2006-03-14
All Time Low
1,760
All Time Low Change
127.84%
All Time Low Date
1998-06-29
ATR
150
Beta
0.31
Beta1y
0.15
Beta2y
0.27
Ch YTD
-3.49
High
4,080
High52
5,490
High52 Date
2025-07-29
High52ch
-26.96%
Low
3,950
Low52
3,410
Low52 Date
2026-03-09
Low52ch
17.6%
Ma50ch
5.02%
Price vs 200-day SMA
-3.33%
RSI
55.87
RSI Monthly
41.05
RSI Weekly
50.01
Sharpe ratio
0x
Sortino ratio
0.2
Total Return
-0.11%
Tr YTD
-3.49
Tr15y
-36.49%
Tr1m
13.28%
Tr1w
-3.37%
Tr3m
-4.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
KRW 9.7B
Operating Income Growth
-5.24
Operating Income Growth Q
-32.15
Operating margin
5.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
16,300,622%
Net Borrowing
-20,754,233,380
Shares Insiders
21.64%
Shares Institutions
0.65%
Shares Out
21,912,592
Shares Qo Q
-43.72%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
KRW -1.9B
Average Volume
110,531.65x
Bv Per Share
13,692.4
CAPEX
KRW -652.9M
Ch10y
-51.33
Ch15y
-40.15
Ch1m
13.28
Ch1w
-3.37
Ch1y
0.25
Ch20y
-86.36
Ch3m
-4.41
Ch3y
-38.12
Ch5y
-68.17
Ch6m
0.12
Change
0.25%
Change From Open
-1.72
Close
4,000
Days Gap
2
Depreciation Amortization
4,627,970,000
Dollar Volume
243,535,320
Earnings Date
2026-05-14
EBIT
KRW 9.7B
EBITDA
KRW 14.3B
EPS
KRW 6.5
F Score
4
FCF
KRW -1.9B
FCF EV Yield
-2.08x
FCF Per Share
KRW -88.52
Financing CF
-20,485,580,620
Fiscal Year End
December
Founded
1,957
Graham Number
1414.74419
Graham Upside
-64.72
Income Tax
KRW -2.4B
Investing CF
-559,589,310
Is Primary Listing
1
Last Earnings Date
2025-11-14
Last Report Date
2025-03-31
Last Split Date
2014-11-17
Last Split Type
Reverse
Lynch Fair Value
KRW 32.48
Lynch Upside
-99.19
Ma150
4,038
Ma150ch
-0.69%
Ma20
3,925.5
Ma20ch
2.15%
Net CF
-22,331,992,050
Next Earnings Date
2026-05-14
Open
4,080
Position In Range
46.15
Ppne
38,263,989,960
Price Date
2026-05-08
Price EBITDA
KRW 6.15
Ptbv Ratio
0.35
Relative Volume
0.55x
Revenue
171,658,205,090x
Tax By Revenue
-1.38x
Tr20y
-84.58%
Tr6m
0.12%
Volume
60,732
Z Score
1.9
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KRX/004720 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/004720 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+0.3%
S&P 500 1Y: n/a
3Y total return
-38.1%
S&P 500 3Y: n/a
5Y total return
-68.2%
S&P 500 5Y: n/a
10Y total return
-51.3%
S&P 500 10Y: n/a
Ownership

Who owns KRX/004720?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.7%
Share of float held by funds and institutions
Insider ownership
+21.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

KRX/004720 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
55.9
Neutral momentum band
Price vs 200-day MA
-3.3%
50/200-day relationship not available
Beta (5Y)
0.31
Less volatile than the market
Sharpe ratio
0.00
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KRX/004720

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/004720 stock rating?

krx/004720 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/004720 analysis?

The full report lives at /stocks/krx/004720/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/004720?

The latest report frames krx/004720 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/004720 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.